NY-ESTÉE-LAUDER
Today, The Estée Lauder Companies (NYSE:EL) (“ELC”) announced key leadership appointments for its international business, which follow the announcement that Cedric Prouvé, currently Group President, International, will retire in June 2022 after an exceptional career.
The following appointments will be effective February 1, 2022:
- Peter Jueptner, currently President, Europe, Middle East, and Africa (EMEA) will succeed Cedric, and will be named President, International , reporting directly to Fabrizio Freda, President and Chief Executive Officer. Peter will be based in New York and will join our Executive Leadership Team Alignment (ELTA), while remaining a member of our Executive Leadership Team (ELT).
- Nadine Graf, currently Vice President, General Manager, EMEA Markets will succeed Peter, and will be named Senior Vice President, General Manager, EMEA , reporting directly to Peter. She will be based in Paris and will join the company’s ELT.
“We are proud of the exceptional depth and quality of internal talent across our organization and ELC remains committed to investing in and growing our talent around the world. As Cedric steps into his well-deserved retirement, we are pleased to elevate Peter and Nadine – two dynamic, internally-trained, and highly experienced leaders into these roles of greater responsibility,” said Fabrizio Freda . “Peter and Nadine each possess extensive first-hand leadership experiences in our regions and affiliates and deep global expertise across all aspects of prestige beauty, making them uniquely qualified to lead our winning International and EMEA businesses, respectively.”
Please find further information about Peter’s and Nadine’s respective appointments below.
Peter Jueptner Appointed President, International
A seasoned and visionary global leader who, throughout his career, has designed and implemented breakthrough winning business models, supported the growth and development of talent, and promoted a team culture of agility and transformation, Peter is uniquely qualified to lead ELC’s winning international business.
As President, International, Peter will oversee the company’s global network of Region Presidents and Affiliate General Managers spanning over 35 affiliates doing business in 150+ countries and territories across our international footprint. In this capacity, Peter will steer the strategic growth of our international organization, overseeing innovation pipelines and strategic third-party relationships with key global retailers and commercial partners to drive our business across established and emerging markets. He will also collaborate closely with our Group and Brand Presidents and Function leaders to integrate global marketing strategies in the international markets.
As President, EMEA since 2016, Peter has leveraged his deep brand, regional, and operational expertise overseeing this important region, where he successfully led the regional strategy, commercial operations and business growth for 17 affiliates, spanning more than 25 countries and covering nearly half of the world’s population. In this role, Peter maintained a consistent focus on ELC’s values, culture, and commitments while driving exceptional performance, and has spearheaded numerous growth opportunities and led critical share gain throughout EMEA’s diverse and complex landscape.
Over the past five years, Peter has led his team in a region-wide transformation approach to further establish EMEA as a multi-faceted, effective, and profitable go-to-market region powered by multiple engines of growth across channels, geographies, and brands. Through this effort, Peter established the region’s Online team and strengthened EMEA’s emerging market portfolio, which is currently the company’s fastest-growing set of emerging markets outside of China. Peter and his team also diversified brand growth across the region, with the majority of regional growth coming from more than 10 of ELC’s powerful brands.
Notably, Peter successfully steered the region through the volatility of the past year and a half, continuing to drive the business amidst the many challenges brought on by the COVID-19 pandemic. He did this while maintaining a clear and caring connection with the EMEA team, supporting them to emerge strongly from the challenges of the past 18 months.
Prior to this, Peter was the Executive Vice President, Strategy, New Business Development and Transformation Initiatives, a role he held since joining ELC in 2009. In this role, he helped oversee the development and execution of the company’s corporate strategy, which delivered record results throughout his tenure, including consistent top-line growth ahead of the global prestige beauty industry. Additionally, he played a key role in continuing to strengthen and expand the company’s powerful portfolio of prestige beauty brands, overseeing a number of acquisitions. As the leader of the company’s strategic initiatives during this time, Peter possesses a unique depth of knowledge at the forefront of industry insights and the biggest opportunities critical to the long-term growth of the company.
“Throughout his impressive career, Peter has continuously demonstrated a people-first approach, and has been strongly committed to driving transparency and innovation that challenge the status quo, while nurturing a culture of diversity, inclusivity, and equity within his teams and across the enterprise,” said Fabrizio Freda . “Peter’s inspiring leadership style, business acumen, and granular knowledge of the landscape at the global, regional, and local levels make him perfectly suited to take on the role of President, International.”
Nadine Graf Appointed Senior Vice President, General Manager, EMEA
A well-respected, driven, and innovative leader with a strong passion for winning, Nadine’s deep experience across ELC’s EMEA affiliates makes her extremely well-suited to lead this dynamic region.
As Senior Vice President, General Manager, EMEA, Nadine will oversee the regional strategy, commercial operations, and business growth for 17 affiliates across a diverse and complex consumer landscape spanning more than 25 countries. Working closely with the Affiliate General Managers, Nadine will be responsible for strategically developing the region’s engines of growth across channels, geographies, and brands. In this capacity, she will lead Transformation initiatives with a focus on continuing to nurture and strengthen EMEA’s emerging market portfolio.
In her most recent role as Vice President (VP), General Manager (GM), EMEA Markets, Nadine closely collaborated with Peter and the affiliate GMs, as well as brand and function leaders, to help set the strategic direction for the region, ensuring consistent implementation of the strategy and critical operational initiatives across all markets to strengthen and expand ELC’s geographic presence in the region.
As part of this, Nadine led the region’s Transformation agenda, which included implementation of enterprise-wide Transformation priorities focused on brand marketing and creative, as well as sub-category innovation. She also supported strategic capability-building projects in Retail, Online, and Commercial, and developed talent across all affiliates through transparency and strong best practice-sharing.
In addition to her oversight of the affiliate GMs, Nadine played a key role leading the implementation of ELC’s Virtual Selling strategy in EMEA, one of the most bold and innovative enterprise-wide initiatives that has accelerated during the past two years. She also developed a new category management approach and inspired the organization to embrace the region’s “makeup renaissance.”
Prior to her most recent role, Nadine led Clinique in EMEA, where she orchestrated a critical business turnaround for the brand in the region, overseeing best-in-class product launches, achieving impressive retailer and channel differentiation, and establishing a clear hero franchise strategy for the brand regionally. During her tenure, the brand also achieved double-digit growth in Online and gained market share across the region.
“Nadine is highly respected by her teams and peers for her energetic leadership,” said Peter Jueptner . “She has been instrumental throughout her time at ELC in building and retaining high-performing teams, and leads by example with a locally-relevant, consumer-obsessed mindset. These qualities, as well as her steadfast focus on excellence in execution and a digital-first approach, will serve her well as she takes on this elevated role leading EMEA.”
About The Estée Lauder Companies Inc.
The Estée Lauder Companies Inc.
is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, Tommy Hilfiger, M·A·C, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin Paris, TOM FORD BEAUTY, Smashbox, Ermenegildo Zegna, AERIN, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
ELC-C
ELC-L
View source version on businesswire.com: https://www.businesswire.com/news/home/20211028005158/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 13:00:00 CEST | Press release
– Vimseltinib demonstrated statistically significant and clinically meaningful benefit vs placebo in antitumor response – Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the dura
ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 16:09:00 CEST | Press release
ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 16:00:00 CEST | Press release
With median follow-up of 14.3 months, pimicotinib demonstrated increasing ORR over time, from 54% at Week 25 to 76.2%Global Phase 3 MANEUVER study demonstrated ongoing improvements in key secondary endpoints including pain and functionApplication for marketing authorization under review by China National Medical Products Administration (NMPA), with additional applications planned in the U.S. and other marketsNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the stud
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 15:04:00 CEST | Press release
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Second pivotal development program of povetacicept underway with Phase 2b/3 trial initiation in primary membranous nephropathy - - Updated data from RUBY-3 trial of povetacicept accepted for late breaking oral presentation; inaxaplin study design and APOL1-mediated kidney disease related data accepted for poster presentation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B c
Qualcomm Announces Quarterly Cash Dividend17.10.2025 15:00:00 CEST | Press release
Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom